Published in Diabetes Metab Res Rev on October 01, 2011
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care (2013) 1.62
The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention. Front Endocrinol (Lausanne) (2015) 1.04
Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain (2014) 0.99
Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacol Rev (2012) 0.99
Chronic pain with neuropathic characteristics in diabetic patients: a French cross-sectional study. PLoS One (2013) 0.94
Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin. Diabetes Metab Syndr Obes (2013) 0.88
Phase 1/2 open-label dose-escalation study of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with painful diabetic peripheral neuropathy. Mol Ther (2013) 0.85
Preventing and treating foot complications associated with diabetes mellitus. Nat Rev Endocrinol (2015) 0.83
Updates in diabetic peripheral neuropathy. F1000Res (2016) 0.81
Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81
Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy. J Med Food (2013) 0.79
The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr (2014) 0.79
A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy. Clin Drug Investig (2015) 0.77
Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy. J Diabetes Metab (2013) 0.77
[Confocal microscope examination of the corneal nerve plexus as biomarker for systemic diseases : View from the corneal nerve plexus on diabetes mellitus disease]. Ophthalmologe (2017) 0.77
The Facilitative Effect of Transcranial Direct Current Stimulation on Visuospatial Working Memory in Patients with Diabetic Polyneuropathy: A Pre-post Sham-Controlled Study. Front Hum Neurosci (2016) 0.76
Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain. Toxins (Basel) (2016) 0.75
Critical appraisal of international guidelines for the management of diabetic neuropathy: is there global agreement in the internet era? Int J Endocrinol (2015) 0.75
Poor sleep in organ transplant recipients: self-reports and actigraphy. Clin Transplant (2013) 0.75
Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathy. J Pain Res (2014) 0.75
Diffusion tensor imaging of the sural nerve in normal controls. Clin Imaging (2014) 0.75
Incidence of diabetic peripheral neuropathic pain in primary care - a retrospective cohort study using the United Kingdom General Practice Research Database. Pragmat Obs Res (2013) 0.75
Pharmacological treatment of diabetic peripheral neuropathy. P T (2015) 0.75
Vitamin D for the treatment of painful diabetic neuropathy. BMJ Open Diabetes Res Care (2016) 0.75
Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice. Oxid Med Cell Longev (2016) 0.75
Painful neuropathy in a diabetic patient resulting from lung cancer and not diabetes: A case report. Oncol Lett (2015) 0.75
Prevalence, discomfort and self-relief behaviours of painful diabetic neuropathy in Taiwan: a cross-sectional study. BMJ Open (2016) 0.75
Pharmacological interventions for painful diabetic neuropathy: Comparative analysis using network meta-analysis. J Diabetes Investig (2015) 0.75
Pilot Study of Exercise Therapy on Painful Diabetic Peripheral Neuropathy. Pain Med (2015) 0.75
Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52-week, open-label study. J Diabetes Investig (2015) 0.75
[Diabetic neuropathy]. Wien Klin Wochenschr (2016) 0.75
Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy. Diabetologia (2017) 0.75
[Diabetic neuropathy]. Wien Klin Wochenschr (2012) 0.75
A Systematic Review of Treatment of Painful Diabetic Neuropathy by Pain Phenotype versus Treatment Based on Medical Comorbidities. Front Neurol (2017) 0.75
Psychological and Biomechanical Aspects of Patient Adaptation to Diabetic Neuropathy and Foot Ulceration. Curr Diab Rep (2017) 0.75
Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model. Psychopharmacology (Berl) (2017) 0.75
The Diabetic Foot as a Proxy for Cardiovascular Events and Mortality Review. Curr Atheroscler Rep (2017) 0.75
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
Meningococcal disease. N Engl J Med (2001) 8.50
Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet (1992) 6.48
Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med (1997) 5.73
Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med (1993) 5.45
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa. Lancet (2000) 4.35
Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis (1998) 3.97
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis (1999) 3.92
Algorithm for neuropathic pain treatment: an evidence based proposal. Pain (2005) 3.92
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care (1999) 3.27
The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med (2002) 3.22
Efficacy of meningococcal vaccine and barriers to vaccination. JAMA (1998) 2.92
Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med (2011) 2.91
Clinical signs for the recognition of children with moderate or severe anaemia in western Kenya. Bull World Health Organ (1997) 2.73
Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil (2006) 2.61
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet (1992) 2.52
Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia (2003) 2.45
Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis (1999) 2.32
Cat scratch disease in the United States: an analysis of three national databases. Am J Public Health (1993) 2.26
Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol (2001) 2.12
The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Diabet Med (2014) 2.03
Statins and risk of polyneuropathy: a case-control study. Neurology (2002) 1.97
Risk factors for meningococcal disease in college students. JAMA (2001) 1.94
Diabetes, hyperglycemia and glycosuria among Indians, Malays and Africans (Bantu) in Cape Town, South Africa. Diabetes (1969) 1.88
Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis (2001) 1.82
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Eur J Neurol (2009) 1.73
Impaired peripheral vasomotion in diabetes. Diabetes Care (1996) 1.67
Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg (2001) 1.66
Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia (2005) 1.64
Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev (2011) 1.62
Assessment of potential indicators for protein-energy malnutrition in the algorithm for integrated management of childhood illness. Bull World Health Organ (1997) 1.61
Increased Langerhan cell density and corneal nerve damage in diabetic patients: role of immune mechanisms in human diabetic neuropathy. Cont Lens Anterior Eye (2010) 1.61
Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis (1998) 1.57
The clinical picture of neuropathic pain. Eur J Pharmacol (2001) 1.53
Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur J Clin Invest (2002) 1.52
Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study. Diabetes Care (2000) 1.52
Prevalence of glycosuria and diabetes among Indians and Bantu. S Afr Med J (1969) 1.50
Body weight and the pituitary response to hypothalamic releasing hormones in patients with anorexia nervosa. J Clin Endocrinol Metab (1976) 1.49
Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. Br Med J (Clin Res Ed) (1986) 1.49
Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. J Clin Microbiol (2000) 1.48
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis (1999) 1.47
Leptospirosis among patients presenting with dengue-like illness in Puerto Rico. Acta Trop (2005) 1.45
Serious harm from inpatient hypoglycaemia: a survey of hospitals in the UK. Diabet Med (2014) 1.43
Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group. J Infect Dis (1992) 1.43
Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract (2001) 1.41
Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis (2000) 1.41
Detection and management of lipid disorders in diabetic patients. A commentary for clinicians. Diabetes Care (1992) 1.39
High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia (2007) 1.39
[Syndrome of headache, transitory neurological deficits and lymphocytosis in the cerebrospinal fluid]. Ugeskr Laeger (2000) 1.38
Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care (1998) 1.37
Toxic shock syndrome in the United States: surveillance update, 1979 1996. Emerg Infect Dis (2000) 1.35
Raised proinsulin concentration as early indicator of beta cell dysfunction. BMJ (1991) 1.34
Serologic responses to Bartonella and Afipia antigens in patients with cat scratch disease. Pediatrics (1995) 1.33
Effect of indirect heating on the postural control of skin blood flow in the human foot. Clin Sci (Lond) (1986) 1.32
Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology (2004) 1.32
Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil (2009) 1.32
Pain and dysesthesia in patients with spinal cord injury: A postal survey. Spinal Cord (2001) 1.30
Insulin reserve in patients with chronic pancreatitis. Lancet (1968) 1.30
Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J (1997) 1.30
Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol (1975) 1.28
Insulin-producing islet cell tumors. Endocrinol Metab Clin North Am (1989) 1.27
Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med (2011) 1.26
The hypoalgesic effect of tramadol in relation to CYP2D6. Clin Pharmacol Ther (1996) 1.26
Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet Med (2011) 1.24
Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med (2003) 1.22
Risk of diabetes-related amputation in South Asians vs. Europeans in the UK. Diabet Med (2002) 1.21
The diabetic foot: the scope of the problem. J Fam Pract (2000) 1.21
Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy. Diabet Med (2009) 1.20
Diabetic diarrhea and somatostatin. Ann Intern Med (1986) 1.20
Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis. Emerg Infect Dis (1996) 1.19
Psycho-educational interventions for children and young people with Type 1 diabetes. Diabet Med (2006) 1.18
Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol (2013) 1.17
Non-insulin-dependent diabetes mellitus among First Nations children. New entity among First Nations people of north western Ontario. Can Fam Physician (1996) 1.17
QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab (1987) 1.16
Increased incidence of coronary disease in people with impaired glucose tolerance: link with increased lipoprotein(a) concentrations? BMJ (1992) 1.16
Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease. Diabet Med (2002) 1.16
Lipid-lowering drugs and risk of myopathy: a population-based follow-up study. Epidemiology (2001) 1.15
Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet Med (2002) 1.14
Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia (2009) 1.13
Case 22-1992--pathogenesis of cat scratch disease. N Engl J Med (1992) 1.13
Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg (1997) 1.13
MEN I pancreas: a histological and immunohistochemical study. World J Surg (1984) 1.12
Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team. Clin Infect Dis (2000) 1.12
Nonfunctioning malignant neuroendocrine tumors of the pancreas. Surgery (1986) 1.10
Clinical review 72: diagnosis and management of functioning islet cell tumors. J Clin Endocrinol Metab (1995) 1.10
Gait abnormalities in diabetic neuropathy. Diabetes Care (1997) 1.10
The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer. Br J Cancer (2008) 1.10
Lesson of the week: Hypothyroidism mimicking intra-abdominal malignancy. BMJ (2002) 1.09
A role for islet neogenesis in curing diabetes. Diabetologia (2009) 1.09
Microgastrinomas of the duodenum. A cause of failed operations for the Zollinger-Ellison syndrome. Ann Surg (1989) 1.08
Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol (1996) 1.08
Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest (1997) 1.08
Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease. Vaccine (1999) 1.07
Suspected Brazilian purpuric fever in a toddler with overwhelming Epstein-Barr virus infection. Clin Infect Dis (1998) 1.06
Benefits of a multidisciplinary approach in the management of recurrent diabetic foot ulceration in Lithuania: a prospective study. Diabetes Care (1999) 1.06
Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. Bull World Health Organ (2002) 1.05
Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine. Eur J Clin Pharmacol (1993) 1.04